<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02863003</url>
  </required_header>
  <id_info>
    <org_study_id>LACOG 0515</org_study_id>
    <nct_id>NCT02863003</nct_id>
  </id_info>
  <brief_title>Multicenter Database of Patients With Germ Cell Tumor</brief_title>
  <official_title>Multicenter Database of Patients With Germ Cell Tumor in Order to Characterize Clinicopathologically and to Evaluate Cancer Treatment Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Latin American Cooperative Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Latin American Cooperative Oncology Group</source>
  <brief_summary>
    <textblock>
      Retrospective and prospective cohort of patients with germ cell tumor in treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to create a multicenter database in order to
      characterize epidemiologically and clinicopathologically patients with germ cell tumor and
      evaluate the prognosis and clinical outcomes during cancer treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>16 Years</target_duration>
  <primary_outcome>
    <measure>Brazilian multicenter database in order to collect and analyze data from diagnosis and treatment of patients with germ cell tumor</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Description of demographic characteristics of testicular germ cell tumor patients in Brazil</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The clinical and pathological characteristics of testicular germ cell tumor patients in Brazil.</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment according to staging and relapse of patients diagnosed with testicular germ cell tumor in Brazil</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease free survival of patients diagnosed with germ cell tumor stage 1.</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival of patients diagnosed with germ cell tumor stage 1.</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease free survival of patients diagnosed with germ cell tumor stages 2 and 3.</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival of patients diagnosed with germ cell tumor stages 2 and 3.</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International prognostic factors in patients with advanced germ cell tumor (stages 2 and 3) stablished by the International Germ Cell Cancer Collaborative Group in brazilian patients.</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment outcome in different populations: in patients with brain metastasis, patients with germinative tumor extragonodal, surgery outcome in patients with nonseminomous tumor and ressection of residual lesion after chemotherapy</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease free survival of patients diagnosed with disease relapse after first line chemotherapy</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival of patients diagnosed with disease relapse after first line chemotherapy</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic model after first line treatment failure with cisplatin, stablished by the International Prognostic Factors Study Group in brazilian patients.</measure>
    <time_frame>From 2000 to 2025</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Neoplasms, Germ Cell and Embryonal</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Men with diagnosis of testicular, retroperitonium or mediastinal primary tumor.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patients with diagnosis of testicular, retroperitoneum or mediastinal primary
             tumor.

          -  Histological confirmation of germ cell tumor or clinical condition based on the
             elevation of tumor markers (AFP, HCG e/ou DHL) associated to testicular mass or/and
             retroperitoneal lymphnode enlargement or/and mediastinal mass.

          -  Medical records of the disease and treatment

        Exclusion Criteria:

          -  Female patients diagnosed with ovary germ cell tumor

          -  Male patients diagnosed with germ cell tumor in other locations.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustavo Werutsky, MD</last_name>
    <role>Study Director</role>
    <affiliation>Latin American Cooperative Oncology Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Diogo Bastos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto do Cancer do Estado de São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Voelcker</last_name>
    <phone>55 51 3384 5334</phone>
    <email>laura.voelcker@lacog.org.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raíra Maschmann</last_name>
    <phone>55 51 3384 5334</phone>
    <email>raira.maschmann@lacog.org.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CPO - Pucrs</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Virginia Webber</last_name>
    </contact>
    <investigator>
      <last_name>André Fay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Israelita Albert Einstein</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernanda Cardoso</last_name>
    </contact>
    <investigator>
      <last_name>Oren Smaletz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital São José</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristiane Ibrahim</last_name>
    </contact>
    <investigator>
      <last_name>Fábio Schutz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICESP</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bárbara Penna</last_name>
    </contact>
    <investigator>
      <last_name>Diogo Bastos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Dzik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2016</study_first_submitted>
  <study_first_submitted_qc>August 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>August 8, 2016</last_update_submitted>
  <last_update_submitted_qc>August 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms, Germ Cell and Embryonal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

